SMTL ID : 4i2p.1

Crystal structure of HIV-1 reverse transcriptase in complex with rilpivirine (TMC278) based analogue

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.30 Å

Oligo State

hetero-1-1-mer

Ligands

1 x G73: (2E)-3-[4-({6-[(4-methoxyphenyl)amino]-7H-purin-2-yl}amino)-3,5-dimethylphenyl]prop-2-enenitrile(Non-covalent)

G73.1: 14 residues within 4Å: Chain A: P.97, L.102, K.103, K.105, V.181, Y.183, Y.190, F.229, W.231, L.236, H.237, P.238, Y.320 Chain B: E.138 17 PLIP interactions: 15 interactions with chain A, 2 interactions with chain B Hydrophobic interactions: A:P.97, A:K.105, A:V.181, A:Y.183, A:Y.183, A:Y.183, A:Y.183, A:Y.190, A:W.231, A:L.236 Hydrogen bonds: A:K.103, A:K.103, A:K.103, A:K.103, A:K.105 Water bridges: B:E.138, B:E.138

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Johnson, B.C. et al., A comparison of the ability of rilpivirine (TMC278) and selected analogues to inhibit clinically relevant HIV-1 reverse transcriptase mutants. Retrovirology (2012)

Release Date

2013-01-16

Peptides

Gag-Pol polyprotein: A
Gag-Pol polyprotein: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Gag-Pol polyprotein

Gag-Pol polyprotein

Related Entries With Identical Sequence